Other Vaccines - Zimbabwe

Zimbabwe

Highlights

The Other Vaccines market in Zimbabwe is estimated to generate a revenue of US$2.55m by the year 2024.
It is expected to exhibit a compound annual growth rate (CAGR 2024-2029) of 8.67%, leading to a market volume of US$3.87m by 2029.
In terms of global comparison, United States is projected to generate the highest revenue in the Other Vaccines market, with US$24.73bn in 2024.
Zimbabwe has been making significant strides in the development and distribution of other vaccines, particularly in addressing the needs of rural communities.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other Vaccines market in Zimbabwe has seen significant developments in recent years, driven by a combination of customer preferences, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Zimbabwean customers have shown a growing interest in preventive healthcare measures, including vaccines. This trend is driven by a rising awareness of the importance of vaccination in preventing the spread of infectious diseases. As a result, there has been an increasing demand for Other Vaccines, which protect against diseases such as hepatitis B, HPV, and meningococcal disease.

Trends in the market: The Other Vaccines market in Zimbabwe has been growing steadily in recent years, driven by an increasing demand for preventive healthcare measures. The market is expected to continue to grow in the coming years, as more people become aware of the importance of vaccination. In addition, the government of Zimbabwe has launched several vaccination campaigns aimed at increasing the vaccination rate in the country. These campaigns have been successful in increasing the uptake of vaccines, including Other Vaccines.

Local special circumstances: Zimbabwe has a high burden of infectious diseases, including HIV/AIDS, tuberculosis, and malaria. This has led to a growing awareness of the importance of vaccination in preventing the spread of infectious diseases. In addition, Zimbabwe has a relatively young population, which is more susceptible to infectious diseases. As a result, there is a growing demand for preventive healthcare measures, including vaccines.

Underlying macroeconomic factors: Zimbabwe has experienced significant economic challenges in recent years, including high inflation and a shortage of foreign currency. These challenges have had an impact on the healthcare system, including the availability of vaccines. However, the government of Zimbabwe has made efforts to improve the healthcare system, including increasing the budget for healthcare and launching vaccination campaigns. In addition, international organizations such as the World Health Organization have provided support to the healthcare system in Zimbabwe, including the provision of vaccines.In conclusion, the Other Vaccines market in Zimbabwe has seen significant developments in recent years, driven by a combination of customer preferences, local special circumstances, and underlying macroeconomic factors. The market is expected to continue to grow in the coming years, as more people become aware of the importance of vaccination and the government of Zimbabwe continues to invest in the healthcare system.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.